Xeltis has welcomed Stefan K. Widensohler as the new Chairman of the Board, following his nomination by Xeltis Board members. Stefan has over 25 years of experience as a healthcare entrepreneur and has been an active investor and board member of several companies in the industry, including the Board of St. Jude Medical until its acquisition. He currently serves as a Director at Millipede, Inc., USA, PINE Medical, Hong Kong, Nobil BioRicerche, Italy and is acting as Vice Chairman of BVMed (Germany’s Health Care Industry Association), Advisory Board Member at TowerBrook Capital Partners LLP and at BGM Associates, Strategic Health Tech Advisors.
In addition, Karen Wagner has joined Xeltis Board of Directors, replacing her colleague Josep L.l. Sanfeliu. Dr. Karen Wagner is a senior executive and entrepreneur with close to 20 years’ experience in the biopharmaceutical industry and a General Partner at Ysios Capital.
“Stefan and Karen bring over 40 years of experience in the healthcare industry to Xeltis. We look forward to working closely with them on the progression towards the company’s next milestones,” stated Xeltis’ CEO Laurent Grandidier. “We extend our gratitude and appreciation to Michel Darnaud, our former Chairman, for his support throughout the earlier stages of our venture, and to Josep L.l. Sanfeliu who had joined in November 2017. We wish them all the best for their future endeavors” he added.